MENLO PARK, Calif., March 25 Evalve, Inc., the leader inthe development of devices for the percutaneous repair of cardiac valves,announced today CE Mark approval for its MitraClip(R) system. The ...
MENLO PARK, Calif., Nov. 27 Evalve, Inc., the leader inthe development of devices for the percutaneous repair of cardiac valves,announced today that it had successfully completed a $60 million Series ...
In an attempt to bolster its fast-growing vascular business with new products to treat heart disease, Abbott Laboratories plans to buy a maker of heart valve repair devices for more than $400 million.
Evalve Inc., a Menlo Park, Calif.-based maker of devices for the percutaneous repair of cardiac valves, has raised $60 million in Series D funding. BBT Fund led the round, and was joined by Emergent ...
LOS ANGELES, Sept 10 (Reuters) - Abbott Laboratories said on Thursday it has agreed to acquire the 90 percent of Evalve Inc that it does not already own for up to $410 million to secure a leadership ...
Evalve, a Menlo Park, Calif., developer of minimally invasive heart-valve repair implants, raised $60 million in a fourth funding round. Evalve’s device is designed to replace risky open-heart surgery ...
Illinois health-care giant Abbott Laboratories agreed to buy Evalve Inc. for $320 million in cash. Menlo Park-based Evalve makes devices used in heart valve repair. Abbott (NYSE: ABT) could also pay ...
The Everest II Clinical Trial is a study comparing nonsurgical repair for severe mitral valve regurgitation with conventional surgery. The MitraClip procedure is performed in a cardiac catheterization ...
This morning's roundup of the latest venture capital news and analysis across the Web: The 10-Year Itch - After investing more than $117 million in medical-device maker Evalve Inc. over the past 10 ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. © 2026 American City Business Journals. All rights ...
So a family member of mine has a busted mitral valve in their heart. The cardiologist is recommending this new procedure that's undergoing Phase II trials. The product is called a Mitraclip, and the ...
MENLO PARK, Calif., Dec. 4 /PRNewswire/ -- Evalve, Inc., the leader in the development of devices for the percutaneous repair of cardiac valves, announced today that it had successfully completed a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results